AU2009257174A1 - Novel receptor hetero-dimers/-oligomers - Google Patents
Novel receptor hetero-dimers/-oligomers Download PDFInfo
- Publication number
- AU2009257174A1 AU2009257174A1 AU2009257174A AU2009257174A AU2009257174A1 AU 2009257174 A1 AU2009257174 A1 AU 2009257174A1 AU 2009257174 A AU2009257174 A AU 2009257174A AU 2009257174 A AU2009257174 A AU 2009257174A AU 2009257174 A1 AU2009257174 A1 AU 2009257174A1
- Authority
- AU
- Australia
- Prior art keywords
- receptor
- vasopressin
- angiotensin
- test compound
- hetero
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2009257174A AU2009257174A1 (en) | 2008-06-09 | 2009-06-09 | Novel receptor hetero-dimers/-oligomers |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2008902974 | 2008-06-09 | ||
| AU2008902974A AU2008902974A0 (en) | 2008-06-09 | Novel receptor hetero-dimers/-oligomers | |
| AU2009257174A AU2009257174A1 (en) | 2008-06-09 | 2009-06-09 | Novel receptor hetero-dimers/-oligomers |
| PCT/AU2009/000720 WO2009149493A1 (fr) | 2008-06-09 | 2009-06-09 | Nouveaux récepteurs hétérodimères/hétéro-oligomères |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2009257174A1 true AU2009257174A1 (en) | 2009-12-17 |
Family
ID=41416271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2009257174A Abandoned AU2009257174A1 (en) | 2008-06-09 | 2009-06-09 | Novel receptor hetero-dimers/-oligomers |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2009257174A1 (fr) |
| WO (1) | WO2009149493A1 (fr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9613470D0 (en) * | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
| US7417038B1 (en) * | 1998-10-15 | 2008-08-26 | Imperial Innovations Limited | Methods of treating cachexia |
| ATE367815T1 (de) * | 2000-10-04 | 2007-08-15 | Astellas Pharma Inc | Verwendung von einem vasopressin-antagonisten wie conivaptan zur herstellung eines medikaments für die behandlung der pulmonalen hypertension |
| ES2533007T3 (es) * | 2005-12-27 | 2015-04-06 | Otsuka Pharmaceutical Co., Ltd. | Compuesto de benzoacepina soluble en agua y su composición farmacéutica |
-
2009
- 2009-06-09 AU AU2009257174A patent/AU2009257174A1/en not_active Abandoned
- 2009-06-09 WO PCT/AU2009/000720 patent/WO2009149493A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009149493A1 (fr) | 2009-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12083102B2 (en) | Method for treating inflammatory disorders | |
| US20100234417A1 (en) | Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers | |
| Danser | The role of the (pro) renin receptor in hypertensive disease | |
| US20120208843A1 (en) | Method of Using GPR35 to Identify Metabolic-Stabilizing Compounds | |
| Wagenaar et al. | Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats | |
| Zhang et al. | Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection | |
| KR20220070435A (ko) | 질환의 치료를 위한 방법 및 조성물 | |
| AU2009257174A1 (en) | Novel receptor hetero-dimers/-oligomers | |
| US7611832B2 (en) | Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure | |
| CA3139912A1 (fr) | Inhibiteurs d'heteromeres de gpcr et leurs utilisations | |
| US20120100130A1 (en) | Novel Receptor Hetero-Dimers/-Oligomers | |
| Dominici et al. | Therapeutic opportunities in targeting the protective arm of the renin-angiotensin system to improve insulin sensitivity: a mechanistic review | |
| WO2010003170A1 (fr) | Nouveaux hétérodimères/hétéro-oligomères récepteurs | |
| WO2014153044A1 (fr) | Traitement de patients atteints d'une hyponatrémie et d'une maladie cardiaque | |
| WO2010031114A1 (fr) | Nouveaux récepteurs hétérodimères/-oligomères | |
| WO2010129987A1 (fr) | Nouveaux hétérodimères/hétéro-oligomères récepteurs | |
| ES2770785T3 (es) | Terapia de combinación | |
| Lunder et al. | Peptide mimetic of N‐terminal ghrelin enhances ghrelin‐induced growth hormone secretion and c‐Fos expression in mice | |
| Grämer | Development of a GRK2-inhibitory peptide | |
| HK1192712B (en) | Combination therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |